BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (BGLC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BGLC · as of Jun 8, 2026
Key Statistics
Explore BioNexus Gene Lab Corp. Data
bglc stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bglc competitorsBGLC
ADVB
AEON
APM
CHEK
GLTOStock Performance
Full HistoryAbout BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., spec…
what is bionexus gene lab corp. · bglc stock overview · bionexus gene lab corp. company profile · who is bionexus gene lab corp. ceo · bglc NASDAQ · bionexus gene lab corp. headquarters · bionexus gene lab corp. business segments
About Stock Overview & Key Data
BioNexus Gene Lab Corp. (BGLC) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jan 8, 2021. As of the latest trading session, BGLC stock price is $2.19, with a market capitalization of $4.4M. The stock has returned -28.66% over the past 12 months and -44.56% year-to-date.
In fiscal year 2025, BioNexus Gene Lab Corp. reported revenue of $7.4M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioNexus Gene Lab Corp. (BGLC) stock price is $2.19. The stock is traded on NASDAQ under the ticker symbol BGLC. The 52-week range is $1.92 – $15.60.